These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 18071630)

  • 1. Temporary confusion depending on the usage of naratriptan.
    Kutluhan S; Incekara F; Sozen A; Koyuncuoglu HR; Tak R; Gokalp O; Gultekin F
    J Headache Pain; 2007 Dec; 8(6):340-1. PubMed ID: 18071630
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ischemic colitis associated with naratriptan and oral contraceptive use: a response.
    Malone TD; Kori SH
    Headache; 2005; 45(10):1418-9; author reply 1419-20. PubMed ID: 16324179
    [No Abstract]   [Full Text] [Related]  

  • 3. [Ischemic colitis associated with naratriptan administration].
    Macaigne G; Simon P; Auriault ML; Boivin JF; Froguel E; Chayette C; Cheaib S; Deplus R
    Gastroenterol Clin Biol; 2002 Nov; 26(11):1058-9. PubMed ID: 12483146
    [No Abstract]   [Full Text] [Related]  

  • 4. Headache after frequent use of serotonin agonists zolmitriptan and naratriptan.
    Limmroth V; Kazarawa Z; Fritsche G; Diener HC
    Lancet; 1999 Jan; 353(9150):378. PubMed ID: 9950449
    [No Abstract]   [Full Text] [Related]  

  • 5. Open-label, long-term tolerability of naratriptan for short-term prevention of menstrually related migraine.
    Brandes JL; Smith T; Diamond M; Ames MH
    Headache; 2007 Jun; 47(6):886-94. PubMed ID: 17578540
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and tolerability of naratriptan for short-term prevention of menstrually related migraine: data from two randomized, double-blind, placebo-controlled studies.
    Mannix LK; Savani N; Landy S; Valade D; Shackelford S; Ames MH; Jones MW
    Headache; 2007; 47(7):1037-49. PubMed ID: 17635595
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative efficacy of eletriptan vs. naratriptan in the acute treatment of migraine.
    Garcia-Ramos G; MacGregor EA; Hilliard B; Bordini CA; Leston J; Hettiarachchi J
    Cephalalgia; 2003 Nov; 23(9):869-76. PubMed ID: 14616928
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of naratriptan and sumatriptan in recurrence-prone migraine patients. Naratriptan International Recurrence Study Group.
    Göbel H; Winter P; Boswell D; Crisp A; Becker W; Hauge T; Mihout B; Niewold J; Tørring J
    Clin Ther; 2000 Aug; 22(8):981-9. PubMed ID: 10972634
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Worsening of transformed migraine with naratriptan as prophylactic treatment.
    Pascual J
    Headache; 2000; 40(7):610-1. PubMed ID: 10940106
    [No Abstract]   [Full Text] [Related]  

  • 10. Effect of naratriptan on myocardial blood flow and coronary vasodilator reserve in migraineurs.
    Gnecchi-Ruscone T; Bernard X; Pierre P; Anderson D; Legg N; Enahoro H; Winter PD; Crisp A; Melin JA; Camici PG
    Neurology; 2000 Jul; 55(1):95-9. PubMed ID: 10891912
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sumatriptan and naratriptan tolerability and safety: an update of post-marketing experience.
    Welch KM
    Cephalalgia; 2001; 21 Suppl 1():25-8. PubMed ID: 11678818
    [No Abstract]   [Full Text] [Related]  

  • 12. Naratriptan is effective and well tolerated in the acute treatment of migraine. Results of a double-blind, placebo-controlled, crossover study. The Naratriptan S2WA3003 Study Group.
    Mathew NT; Asgharnejad M; Peykamian M; Laurenza A
    Neurology; 1997 Dec; 49(6):1485-90. PubMed ID: 9409334
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Looking forward: the expanding utility of sumatriptan and naratriptan.
    Cady R
    Cephalalgia; 2001; 21 Suppl 1():35-8. PubMed ID: 11678821
    [No Abstract]   [Full Text] [Related]  

  • 14. Tolerability and efficacy of naratriptan tablets in the acute treatment of migraine attacks for 1 year. Naratriptan Long-Term Study Group.
    Heywood J; Bomhof MA; Pradalier A; Thaventhiran L; Winter P; Hassani H
    Cephalalgia; 2000 Jun; 20(5):470-4. PubMed ID: 11037743
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of rizatriptan 10 mg vs. naratriptan 2.5 mg in migraine.
    Bomhof M; Paz J; Legg N; Allen C; Vandormael K; Patel K
    Eur Neurol; 1999; 42(3):173-9. PubMed ID: 10529545
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Building on the sumatriptan experience: the development of naratriptan.
    Connor HE
    Cephalalgia; 2001; 21 Suppl 1():32-4. PubMed ID: 11678820
    [No Abstract]   [Full Text] [Related]  

  • 17. Naratriptan.
    Massiou H
    Curr Med Res Opin; 2001; 17 Suppl 1():s51-3. PubMed ID: 12463278
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Naratriptan: an alternative for migraine.
    Dulli DA
    Ann Pharmacother; 1999 Jun; 33(6):704-11. PubMed ID: 10410185
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preclinical neuropharmacology of naratriptan.
    Lambert GA
    CNS Drug Rev; 2005; 11(3):289-316. PubMed ID: 16389295
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tolerability and efficacy of naratriptan tablets with long-term treatment (6 months). Naratriptan Long-term Study Group.
    Bomhof MA; Heywood J; Pradalier A; Enahoro H; Winter P; Hassani H
    Cephalalgia; 1998 Jan; 18(1):33-7. PubMed ID: 9601622
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.